天眼查商业履历信息显示，天域生物科技股份有限公司，成立于2000年，位于重庆市，是一家以从事公 共设施管理业为主的企业。企业注册资本29014.624万人民币，实缴资本11964万人民币。公司法定代表 人为史东伟。 通过天眼查大数据分析，天域生物科技股份有限公司共对外投资了62家企业，参与招投标项目331次， 知识产权方面有商标信息98条，专利信息56条，此外企业还拥有行政许可11个。 来源：金融界 资金流向方面，今日主力资金净流入2450.88万元，占比成交额12.69%。其中，超大单净流入40.74万 元、占成交额0.21%，大单净流入2410.14万元、占成交额12.48%，中单净流出流出94.36万元、占成交 额0.49%，小单净流出2356.52万元、占成交额12.2%。 天域生物最新一期业绩显示，截至2025一季报，公司营业总收入2.25亿元、同比增长6.68%，归属净利 润1376.82万元，同比增长52.50%，扣非净利润638.92万元，同比减少457.16%，流动比率1.127、速动比 率0.955、资产负债率75.91%。 金融界消息 截至2025年8月25日收盘，天域生物（603717 ...

Group 1 - The aquaculture sector increased by 0.14% on August 22, with *ST Tianshan leading the gains [1] - The Shanghai Composite Index closed at 3825.76, up 1.45%, while the Shenzhen Component Index closed at 12166.06, up 2.07% [1] - Key stocks in the aquaculture sector showed varied performance, with *ST Tianshan closing at 8.73, up 0.92%, and Zhengbang Technology at 2.92, up 0.69% [1] Group 2 - The aquaculture sector experienced a net outflow of 576 million yuan from main funds, while retail investors contributed a net inflow of 333 million yuan [2] - The trading volume for *ST Tianshan was 81,100 hands, with a transaction amount of 70.41 million yuan [1] - Other notable stocks included Wens Foodstuff Group at 17.71, up 0.40%, and Muyuan Foods at 50.35, up 0.28% [1]

序号代码名称最新价涨跌幅主力净流入主力净占比1002100天康生物6.61.072467.41万元9.41%2600975新 五丰6.470.621664.68万元5.92%3603717天域生物8.552.271509.48万元9.71%4002840华统股份 10.750.191368.62万元10.32%5002311海大集团60.220.871161.37万元3.17%6000735罗 牛 山6.440.94684.38 万元3.36%7002157正邦科技2.91.05649.50万元1.74%8300761立华股份19.711.86572.66万元1.67%9002385 大北农4.220.72526.59万元0.92%10603609禾丰股份8.940.68479.32万元6.42% 来源：金融界 8月21日，猪肉概念上涨0.75%，今日主力资金流出1.97亿元，概念股28只上涨，6只下跌。 主力资金净流出居前的分别为牧原股份（1.99亿元）、顺鑫农业（2979.91万元）、新希望（1936.05万 元）、得利斯（1393.17万元）、京基智农（974.31万元）。 ...

Group 1 - The aquaculture sector increased by 0.91% on August 20, with Tianyu Biological leading the gains [1] - The Shanghai Composite Index closed at 3766.21, up 1.04%, while the Shenzhen Component Index closed at 11926.74, up 0.89% [1] - Key stocks in the aquaculture sector showed various performance, with Tianyu Biological closing at 8.36, up 2.58%, and Muyuan Foods at 47.50, up 1.69% [1] Group 2 - The aquaculture sector experienced a net outflow of 232 million yuan from institutional investors, while retail investors saw a net inflow of 178 million yuan [2] - The stock *ST Tianshan saw a significant decline of 16.07%, closing at 9.09 [2] - The trading volume and turnover for major stocks in the aquaculture sector varied, with Muyuan Foods having a turnover of 1.93 billion yuan [2] Group 3 - Major stocks like Muyuan Foods and Shengnong Development had mixed net inflows from different investor types, with Muyuan Foods seeing a net outflow of 81.64 million yuan from retail investors [3] - The net inflow for Shengnong Development from retail investors was 979.36 million yuan, indicating strong retail interest despite overall sector outflows [3] - The data indicates a complex flow of funds within the aquaculture sector, highlighting varying investor sentiments across different stocks [3]

Core Viewpoint - Tianyu Biotechnology Co., Ltd. is currently in the process of enforcing an arbitration ruling regarding performance compensation from Liu Bingsheng, with a total amount of CNY 43,295,330.52 involved in the case [2][3][4]. Group 1: Arbitration Background - On August 17, 2023, the company initiated arbitration against Liu Bingsheng for failing to fulfill performance compensation obligations [3]. - The Shanghai Arbitration Commission issued a ruling on June 16, 2025, requiring Liu Bingsheng to pay CNY 43,295,330.52 as a one-time cash compensation and CNY 314,273 for arbitration fees [3][5]. - The arbitration ruling has been acknowledged and is now enforceable [4]. Group 2: Execution Application - The company applied for enforcement of the ruling on July 11, 2025, due to Liu Bingsheng's failure to comply within the stipulated timeframe [4]. - The enforcement application was accepted by the Haixi Mongolian and Tibetan Autonomous Prefecture Intermediate People's Court on August 18, 2025 [4]. - The enforcement request includes the payment of the compensation amount, arbitration fees, and additional interest for delayed payment [6]. Group 3: Financial Impact and Uncertainties - The execution of the arbitration ruling carries significant uncertainties regarding the timing and realization of the compensation amount, which may affect the company's current and future profits [2][5]. - The company will continue to monitor the progress of the enforcement and fulfill its information disclosure obligations [5].

Market Overview - On August 18, the aquaculture sector rose by 0.41% compared to the previous trading day, with Tianyu Biological leading the gains [1] - The Shanghai Composite Index closed at 3728.03, up 0.85%, while the Shenzhen Component Index closed at 11835.57, up 1.73% [1] Stock Performance - Key stocks in the aquaculture sector showed varied performance, with Tianyu Biological closing at 8.17, up 3.16%, and Shennong Group at 32.08, up 0.56% [1] - Other notable performers included Shengnong Development at 17.28, up 2.67%, and Yike Food at 11.70, up 1.21% [1] Trading Volume and Value - The trading volume for Tianyu Biological was 183,800 shares, with a transaction value of 150 million yuan [1] - Shengnong Development had a trading volume of 380,900 shares, with a transaction value of 654 million yuan [1] Capital Flow - The aquaculture sector experienced a net outflow of 97.087 million yuan from institutional investors, while retail investors saw a net outflow of 124 million yuan [2] - Conversely, speculative funds recorded a net inflow of 221 million yuan [2] Individual Stock Capital Flow - Muyuansheng had a net inflow of 43.3368 million yuan from institutional investors, while it faced a net outflow of 38.4479 million yuan from speculative funds [3] - Shengnong Development also saw a net inflow of 24.6627 million yuan from institutional investors, with a net outflow of 10.6830 million yuan from speculative funds [3]

证券代码：603717 证券简称：天域生物 公告编号：2025-058 天域生物科技股份有限公司 关于业绩补偿仲裁进展暨申请执行的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、业绩补偿仲裁的基本情况 2023 年 08 月 17 日，天域生物科技股份有限公司（以下简称"公司"）以刘 炳生先生未如期履行业绩补偿支付义务为由向上海仲裁委员会提起仲裁申请，并 于 2023 年 08 月 30 日收到上海仲裁委员会送达的"（2023）沪仲案字第 4766 号 争议仲裁案"《仲裁通知书》。2025 年 06 月 16 日，公司收到上海仲裁委员会送 达的《裁决书》，裁决：（1）刘炳生应于本裁决作出之日起十日内向公司支付 业绩承诺一次性现金补偿款人民币 43,295,330.52 元；（2）本案仲裁费人民币 314,273 元（已由公司预缴），由刘炳生承担。刘炳生应于本裁决作出之日起十 1 案件所处的仲裁阶段：申请执行立案受理 上市公司所处的当事人地位：申请执行人 涉案金额：43,295,330.52 元及本案仲 ...

天域生物科技股份有限公司公告业绩补偿仲裁进展。2023年8月公司因刘炳生未履行业绩补偿支付义务 提起仲裁，2025年6月收到裁决书，刘炳生需支付43,295,330.52元补偿款及314,273元仲裁费。因刘炳生 未在规定期限内履行支付义务，公司于2025年向海西州中级人民法院申请强制执行并获受理。 ...

公司公告汇总 截至2025年08月12日，天域生物科技股份有限公司已将前次暂时补充流动资金的募集资金7400万元归还 至募集资金专户。公司拟继续使用不超过人民币6150万元的闲置募集资金暂时补充流动资金，使用期限 自董事会审议通过之日起不超过12个月。公司募集资金总额为人民币402272000元，扣除发行费用后净 额为393865542.38元。截至2025年06月30日，公司对募集资金投资项目累计投入募集资金332634788.44 元，使用闲置募集资金暂时补充流动资金61500000元，募集资金专用账户余额为187615.74元。为提高 募集资金使用效率，降低经营成本，公司拟继续使用不超过6150万元的闲置募集资金暂时补充流动资 金，确保不影响募集资金投资项目实施及募集资金使用。保荐机构、监事会均同意该事项，认为其符合 相关法律法规，不存在变相改变募集资金用途的情形，不影响募集资金投资项目的正常进行。中德证券 有限责任公司作为天域生物科技股份有限公司2020年非公开发行股票的保荐机构，根据相关法规对天域 生物归还募集资金及继续使用部分闲置募集资金暂时补充流动资金的事项进行了核查。天域生物非公开 发行人民币 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603717 证券简称：天域生物 公告编号：2025-057 天域生物科技股份有限公司关于归还募集资金及继续使用部分闲置募集资金暂时补充流动资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 截至2025年08月12日，天域生物科技股份有限公司（以下简称"公司"，曾用名"天域生态环境股份有 限公司"）已将前次暂时补充流动资金的募集资金7,400万元归还至募集资金专户。 ● 公司拟继续使用不超过人民币6,150万元的闲置募集资金暂时补充流动资金，使用期限自董事会审议 通过之日起不超过12个月。 公司于2025年08月12日分别召开第四届董事会第四十二次会议和第四届监事会第三十五次会议，审议通 过了《关于继续使用部分闲置募集资金暂时用于补充流动资金的议案》，同意公司在确保不影响募集资 金投资项目实施及募集资金使用的情况下，继续使用不超过6,150万元的闲置募集资金暂时补充公司流 动资金，使用期限自董事会审议通过之日起不超过12个月。具体情况如下 ...